Abstract
Pseudaminic acids (Pse) are a family of carbohydrates found within bacterial lipopolysaccharides, capsular polysaccharides and glycoproteins that are critical for the virulence of human pathogens. However, a dearth of effective tools for detecting and enriching Pse has restricted study to only the most abundant Pse-containing glycoconjugates. Here we devise a synthesis of α- and β-O-pseudaminylated glycopeptides to generate ‘pan-specific’ monoclonal antibodies (mAbs) that recognize α- and β-configured Pse with diverse N7 acyl groups, as well as its C8 epimer (8ePse), presented within glycans or directly linked to polypeptide backbones. Structural characterization reveals the molecular basis of Pse recognition across a range of diverse chemical contexts. Using these mAbs, we establish a glycoproteomic workflow to map the Pse glycome of Helicobacter pylori, Campylobacter jejuni and Acinetobacter baumannii strains. Finally, we demonstrate that the mAbs recognize diverse capsule types in multidrug-resistant Acinetobacter baumannii and enhance phagocytosis to eliminate infections in mice.

This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Data availability
Structure coordinates have been deposited in the Protein Data Bank (https://www.rcsb.org/) under accession code 9PQS. All mass spectrometry data (RAW files, FragPipe outputs, Rmarkdown scripts and input tables) have been deposited into the PRIDE ProteomeXchange repository with the following data identifiers: PXD056875 for proteomic studies of H. pylori flagellin; PXD046836 for H. pylori P12 enrichments; PXD048493 for H. pylori 26695 enrichments; PXD046858 for C. jejuni NCTC 11168 enrichments; PXD046859 for A. baumannii BAL062 enrichments; and PXD053904 for A. baumannii A74 enrichments. Source data are provided with this paper.
References
Varki, A., Schnaar, R. L. & Schauer, R. in Essentials of Glycobiology [Internet] 3rd edn (eds Varki, A. et al.) Ch. 15 (Cold Spring Harbor Laboratory Press, 2017).
McDonald, N. D. & Boyd, E. F. Structural and biosynthetic diversity of nonulosonic acids (NulOs) that decorate surface structures in bacteria. Trends Microbiol. 29, 142–157 (2021).
Logan, S. M., Kelly, J. F., Thibault, P., Ewing, C. P. & Guerry, P. Structural heterogeneity of carbohydrate modifications affects serospecificity of Campylobacter flagellins. Mol. Microbiol. 46, 587–597 (2002).
Lewis, A. L. et al. Innovations in host and microbial sialic acid biosynthesis revealed by phylogenomic prediction of nonulosonic acid structure. Proc. Natl Acad. Sci. USA 106, 13552–13557 (2009).
de Jong, H., Wösten, M. M. & Wennekes, T. Sweet impersonators: molecular mimicry of host glycans by bacteria. Glycobiology 32, 11–22 (2022).
Stephenson, H. N. et al. Pseudaminic acid on Campylobacter jejuni flagella modulates dendritic cell IL-10 expression via Siglec-10 receptor: a novel flagellin–host interaction. J. Infect. Dis. 210, 1487–1498 (2014).
Lee, I.-M., Wu, H.-Y., Angata, T. & Wu, S.-H. Bacterial pseudaminic acid binding to Siglec-10 induces a macrophage interleukin-10 response and suppresses phagocytosis. Chem. Commun. 60, 2930–2933 (2024).
Knirel, Y. A., Shashkov, A. S., Tsvetkov, Y. E., Jansson, P. E. & Zahringer, U. 5,7-Diamino-3,5,7,9-tetradeoxynon-2-ulosonic acids in bacterial glycopolymers: chemistry and biochemistry. Adv. Carbohydr. Chem. Biochem. 58, 371–417 (2003).
Kiss, E. et al. The rkp-3 gene region of Sinorhizobium meliloti Rm41 contains strain-specific genes that determine K antigen structure. Mol. Plant Microbe Interact. 14, 1395–1403 (2001).
Senchenkova, S. N. et al. Structure of a new pseudaminic acid-containing capsular polysaccharide of Acinetobacter baumannii LUH5550 having the KL42 capsule biosynthesis locus. Carbohydr. Res. 407, 154–157 (2015).
Knirel, Y. A. et al. Sialic acids of a new type from the lipopolysaccharides of Pseudomonas aeruginosa and Shigella boydii. Carbohydr. Res. 133, C5–C8 (1984).
Knirel, Y. A. et al. Somatic antigens of Pseudomonas aeruginosa—the structure of O-specific polysaccharide chains of the lipopolysaccharides from Pseudomonas aeruginosa o5 (Lányi) and immunotype-6 (Fisher). Eur. J. Biochem. 163, 639–652 (1987).
Thibault, P. et al. Identification of the carbohydrate moieties and glycosylation motifs in Campylobacter jejuni flagellin. J. Biol. Chem. 276, 34862–34870 (2001).
Schirm, M. et al. Structural, genetic and functional characterization of the flagellin glycosylation process in Helicobacter pylori. Mol. Microbiol. 48, 1579–1592 (2003).
Posch, G. et al. Characterization and scope of S-layer protein O-glycosylation in Tannerella forsythia. J. Biol. Chem. 286, 38714–38724 (2011).
Horzempa, J., Dean, C. R., Goldberg, J. B. & Castric, P. Pseudomonas aeroginosa 1244 pilin glycosylation: glycan substrate recognition. J. Bacteriol. 188, 4244–4252 (2006).
McNally, D. J. et al. Functional characterization of the flagellar glycosylation locus in Campylobacter jejuni 81-176 using a focused metabolomics approach. J. Biol. Chem. 281, 18489–18498 (2006).
Champasa, K., Longwell, S. A., Eldridge, A. M., Stemmler, E. A. & Dube, D. H. Targeted identification of glycosylated proteins in the gastric pathogen Helicobacter pylori (Hp). Mol. Cell. Proteomics 12, 2568–2586 (2013).
Hopf, P. S. et al. Protein glycosylation in Helicobacter pylori: beyond the flagellins?. PLoS ONE 6, e25722 (2011).
Mahdavi, J. et al. A novel O-linked glycan modulates Campylobacter jejuni major outer membrane protein-mediated adhesion to human histo-blood group antigens and chicken colonization. Open Biol. 4, 130202 (2014).
Andolina, G. et al. Metabolic labeling of pseudaminic acid-containing glycans on bacterial surfaces. ACS Chem. Biol. 13, 3030–3037 (2018).
Wei, R. et al. Synthetic pseudaminic-acid-based antibacterial vaccine confers effective protection against Acinetobacter baumannii infection. ACS Cent. Sci. 7, 1535–1542 (2021).
Lee, I.-M. et al. Pseudaminic acid on exopolysaccharide of Acinetobacter baumannii plays a critical role in phage-assisted preparation of glycoconjugate vaccine with high antigenicity. J. Am. Chem. Soc. 140, 8639–8643 (2018).
Lee, I.-M., Tu, I.-F., Yang, F.-L. & Wu, S.-H. Bacteriophage tail-spike proteins enable detection of pseudaminic-acid-coated pathogenic bacteria and guide the development of antiglycan antibodies with cross-species antibacterial activity. J. Am. Chem. Soc. 142, 19446–19450 (2020).
Wei, R., Liu, H., Tang, A. H., Payne, R. J. & Li, X. A solution to chemical pseudaminylation via a bimodal glycosyl donor for highly stereocontrolled α- and β-glycosylation. Org. Lett. 21, 3584–3588 (2019).
Zhang, Y. et al. Enhanced epimerization of glycosylated amino acids during solid-phase peptide synthesis. J. Am. Chem. Soc. 134, 6316–6325 (2012).
Schoenhofen, I. C., McNally, D. J., Brisson, J. R. & Logan, S. M. Elucidation of the CMP-pseudaminic acid pathway in Helicobacter pylori: synthesis from UDP-N-acetylglucosamine by a single enzymatic reaction. Glycobiology 16, 8C–14C (2006).
Yang, K. Y. et al. Glycosyltransferase Jhp0106 (PseE) contributes to flagellin maturation in Helicobacter pylori. Helicobacter 26, e12787 (2021).
Castric, P., Cassels, F. J. & Carlson, R. W. Structural characterization of the Pseudomonas aeruginosa 1244 pilin glycan. J. Biol. Chem. 276, 26479–26485 (2001).
Kenyon, J. J. & Hall, R. M. Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes. PLoS ONE 8, e62160 (2013).
Lees-Miller, R. G. et al. A common pathway for O-linked protein-glycosylation and synthesis of capsule in Acinetobacter baumannii. Mol. Microbiol. 89, 816–830 (2013).
Iwashkiw, J. A. et al. Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation. PLoS Pathog. 8, e1002758 (2012).
Nigro, S. J., Post, V. & Hall, R. M. Aminoglycoside resistance in multiply antibiotic-resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitals. J. Antimicrob. Chemother. 66, 1504–1509 (2011).
Kenyon, J. J., Marzaioli, A. M., Hall, R. M. & De Castro, C. Structure of the K2 capsule associated with the KL2 gene cluster of Acinetobacter baumannii. Glycobiology 24, 554–563 (2014).
Tkalec, K. I. et al. Glycan-tailored glycoproteomic analysis reveals serine is the sole residue subjected to O-linked glycosylation in Acinetobacter baumannii. J. Proteome Res. 23, 2474–2494 (2024).
Shashkov, A. S. et al. Characterization of the carbapenem-resistant Acinetobacter baumannii clinical reference isolate BAL062 (CC2:KL58:OCL1): resistance properties and capsular polysaccharide structure. mSystems 9, e0094124 (2024).
Baker, S. et al. Exploiting human immune repertoire transgenic mice for protective monoclonal antibodies against antimicrobial resistant Acinetobacter baumannii. Nat. Commun. 15, 7979 (2024).
Yang, X. et al. Discovery of a monoclonal antibody that targets cell-surface pseudaminic acid of Acinetobacter baumannii with direct bactericidal effect. ACS Cent. Sci. 10, 439–446 (2024).
Nielsen, T. B. et al. Monoclonal antibody therapy against Acinetobacter baumannii. Infect. Immun. 89, e0016221 (2021).
Kenyon, J. J., Marzaioli, A. M., Hall, R. M. & De Castro, C. Structure of the K6 capsular polysaccharide from Acinetobacter baumannii isolate RBH4. Carbohydr. Res. 409, 30–35 (2015).
Kenyon, J. J. et al. The K46 and K5 capsular polysaccharides produced by Acinetobacter baumannii NIPH 329 and SDF have related structures and the side-chain non-ulosonic acids are 4-O-acetylated by phage-encoded O-acetyltransferases. PLoS ONE 14, e0218461 (2019).
Nigro, S. J. & Hall, R. M. Loss and gain of aminoglycoside resistance in global clone 2 Acinetobacter baumannii in Australia via modification of genomic resistance islands and acquisition of plasmids. J. Antimicrob. Chemother. 71, 2432–2440 (2016).
Nielsen, T. B. et al. Monoclonal antibody requires immunomodulation for efficacy against Acinetobacter baumannii infection. J. Infect. Dis. 224, 2133–2147 (2021).
Russo, T. A. et al. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect. Immun. 81, 915–922 (2013).
Kappler, K. & Hennet, T. Emergence and significance of carbohydrate-specific antibodies. Genes Immun. 21, 224–239 (2020).
Schmitt, W. & Haas, R. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol. Microbiol. 12, 307–319 (1994).
Tomb, J. F. et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388, 539–547 (1997).
Covacci, A. et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl Acad. Sci. USA 90, 5791–5795 (1993).
Parkhill, J. et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403, 665–668 (2000).
Korlath, J. A., Osterholm, M. T., Judy, L. A., Forfang, J. C. & Robinson, R. A. A point-source outbreak of campylobacteriosis associated with consumption of raw milk. J. Infect. Dis. 152, 592–596 (1985).
Bouvet, P. J. M. & Grimont, P. A. D. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int. J. Syst. Evol. Microbiol. 36, 228–240 (1986).
Nemec, A., Janda, L., Melter, O. & Dijkshoorn, L. Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic. J. Med. Microbiol. 48, 287–296 (1999).
Nhu, N. T. K. et al. Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. J. Med. Microbiol. 63, 1386–1394 (2014).
Shashkov, A. S. et al. Revised structure of the capsular polysaccharide of Acinetobacter baumannii LUH5533 (serogroup O1) containing di-N-acetyllegionaminic acid. Russ. Chem. Bull. 64, 1196–1199 (2015).
Arbatsky, N. P. et al. Revised structure of the polysaccharide from Acinetobacter baumannii LUH5551 assigned as the K63 type capsular polysaccharide. Carbohydr. Res. 535, 109020 (2024).
Kenyon, J. J., Marzaioli, A. M., Hall, R. M. & De Castro, C. Structure of the K12 capsule containing 5,7-di-N-acetylacinetaminic acid from Acinetobacter baumannii isolate D36. Glycobiology 25, 881–887 (2015).
Kenyon, J. J. et al. Acinetobacter baumannii K13 and K73 capsular polysaccharides differ only in K-unit side branches of novel non-2-ulosonic acids: di-N-acetylated forms of either acinetaminic acid or 8-epiacinetaminic acid. Carbohydr. Res. 452, 149–155 (2017).
Iovine, A. et al. Structure of the K58 capsular polysaccharide produced by Acinetobacter baumannii isolate MRSN 31468 includes Pse5Ac7Ac that is 4-O-acetylated by a phage-encoded acetyltransferase. Carbohydr. Res. 547, 109324 (2025).
Kabsch, W. X.D.S. Acta Crystallogr. Sect. D 66, 125–132 (2010).
Storoni, L. C., McCoy, A. J. & Read, R. J. Likelihood-enhanced fast rotation functions. Acta Crystallogr. Sect. D 60, 432–438 (2004).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D 60, 2126–2132 (2004).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D 66, 213–221 (2010).
Talyansky, Y. et al. Capsule carbohydrate structure determines virulence in Acinetobacter baumannii. PLoS Pathog. 17, e1009291 (2021).
Amieva, M. R., Salama, N. R., Tompkins, L. S. & Falkow, S. Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell. Microbiol. 4, 677–690 (2002).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Acknowledgements
E.D.G.-B. acknowledges support from The Walter and Eliza Hall Institute of Medical Research; a Victorian State Government Operational Infrastructure support grant; Rebecca Cooper Fellowship; and National Health and Medical Research Council (NHMRC) Ideas Grants (GNT2027601 and GNT2000517) and Investigator Grant (GNT 2033340). N.E.S. was supported by an Australian Research Council (ARC) Future Fellowship (FT200100270), an ARC Discovery Project Grant (DP210100362) and NHMRC Ideas Grant (GNT2018980). R.J.P. acknowledges funding from an NHMRC Investigator Grant (GNT1174941) and the Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science (CE200100012). D.H.D. acknowledges funding from the National Institutes of Health (NIH) Award R15 (GM109397). We thank the Melbourne Mass Spectrometry and Proteomics Facility of The Bio21 Molecular Science and Biotechnology Institute for access to mass spectrometry instrumentation. We also thank R. Haas for the generous gift of the H. pylori P12 strain.
Author information
Authors and Affiliations
Contributions
A.H.T., L.C., C.E.C.-S., C.L., R.W. and X.L. planned and performed all chemical syntheses; A.W.D. and K.A.S. cultured H. pylori P12 samples; M.K.-L. and L.Z. cultured H. pylori 26695 samples; M.C. and M.L. performed proteomic analyses of H. pylori P12 flagellin; N.M.S. and C.G. raised/characterized mAbs, collected and analyzed all SPR/BLI data, and performed all protein expression and structural biology; A.P.A., K.D.M. and D.H.D. made H. pylori Pse-knockout strains; N.L.S., R.M.H. and J.J.K. sourced A. baumannii strains with diverse K types; L.M.W., C.M. and F.L.S. performed all fluorescence-activated cell sorting experiments; A.L.D. and S.J.C. cultured C. jejuni strains and purified flagellin from these samples; K.I.K. and N.E.S. cultured A. baumannii strains and performed in vitro infection assays; K.I.K., N.M.S. and N.E.S. performed glycopeptide enrichments and glycoproteomic analyses; L.L., G.P.C. and B.P.H. performed in vivo infection assays; N.E.S., E.D.G.-B. and R.J.P. conceived and coordinated the project, and cowrote the paper.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Chemical Biology thanks Micha Fridman, Martin Pabst and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 ExD enabled localisation of native H. pylori glycopeptides FlaA (206-211), FlaB (242-260) and FlgE(281-291).
Localised pseudaminylated events within tryptic digests of flagellin preparation of H. pylori P12 for (A) FlaA 206VSSSAGTGIGVLAEVINK211, (B) FlaB 242ASYNVMATGGTPVQSGTVR260 and (C) FlgE 281ISFTNDSAVSR291. For the FlgE glycopeptide 281ISFTNDSAVSR291 PRM EAD analysis was undertaken to allow localisation of glycosylation events while EThcD was undertaken on 206VSSSAGTGIGVLAEVINK211 and 242ASYNVMATGGTPVQSGTVR260.
Extended Data Fig. 2 Butterfly plots of synthetic verses native glycopeptide 281ISFTNDSAVSR291 of FlgE.
Butterfly plots comparing HCD fragmentation of synthetic glycopeptides bearing an (A) α- or (B) β-configured Pse residue with the identical authentic glycopeptides derived from tryptic digests of flagellin preparation of H. pylori P12. Spectral angle (SA) analysis comparing matched b- and y-ion intensities to native 281ISFTNDSAVSR291 of FlgE supports highest similarity to α-pseudaminylation compared to β-pseudaminylation.
Extended Data Fig. 3 ELISA screening of potential Pse-specific hybridoma supernatant.
(A) ELISA screen of hybridoma supernatant (1:1000) against: (i) control peptides 8, 9 and 10 conjugated to BSA (green), (ii) Pse peptides α-8, α-9 and α-10 conjugated to BSA (orange), and flagellin purified from C. jejuni 81-176, which is also pseudaminylated with Pse5Ac7Ac (blue). Data are presented as mean values ± SD for n = 2. (B) ELISA screen of hybridoma supernatants (1:2000) that are Pse-specific against: (i) α-configured Pse peptides α-8, α-9 and α-10 conjugated to BSA (orange) and (ii) β-configured Pse peptides β-8, β-9 and β-10 conjugated to BSA (blue). Data are presented as mean values ± SD for n = 2.
Extended Data Fig. 4 Binding affinity of Pse analogues to the 1E8 antibody.
SPR sensorgrams and fitted steady-state response data for Pse analogues binding to biotinylated 1E8 Fab’ immobilised on a streptavidin-coated chip.
Extended Data Fig. 5 Pse glycopeptide enrichment from H. pylori 26695.
(A) Volcano plot illustrating the enrichment of Pse5Ac7Ac-modified glycopeptides from H. pylori 26695. (B) EThcD / HCD spectra of the novel glycopeptides derived from Pgi, FlgE and HP_0564.
Extended Data Fig. 6 Pseudaminylation of C. jejuni glycoproteins.
MS/MS EThcD and HCD spectra of (A-B) 447KPSVFSNIWHK457 from FtsA (Q0PAI4_CAMJE) with pseudaminylation localised to Ser452; (C-D) 19KDATTATDAVISTITDVLAK38 from Hup (Q46121_CAMJE) with pseudaminylation localised to Ser30 and (E-F) 191GNDPHDSLVGIK202 from Maf3 (Q0P8S4_CAMJE) with pseudaminylation inferred to Ser197 by the absence of other hydroxyl containing amino acids.
Extended Data Fig. 7 Novel pseudaminic acid-containing glycopeptides identified in A. baumannii A74.
MS/MS EThcD and HCD spectra of unique the glycopeptides identified within A. baumannii A74 corresponding to (A-B) 374APAVANHASSVETK387 of the multidrug efflux RND transporter periplasmic adaptor subunit AdeA (MDW5585830.1); (C-D) 153DAASEALHQITSGGGVTR170 of the CvpA family protein (MDW5584485.1) and (E-F) 55VQQLMDEANATADNPNALASITASADK81 of the tetratricopeptide repeat protein (MDW5583480.1).
Extended Data Fig. 8 Pse-specific surface binding of mAb 1E8 to A. baumannii.
(A) Flow cytometry analysis of A. baumannii strains ATCC19606 (K3 CPS lacking Pse) and A74 (K2 CPS with Pse) either unstained or stained with α-Pse mAb 1E8 alone, α-mouse-AlexaFluor647 alone, or both α-Pse mAb 1E8 and α-mouse-AlexaFluor647. Staining of A. baumannii with α-Pse mAb followed by α-mouse-AlexaFluor647 results in a shift in A647 intensity for A. baumannii A74, while no shift is observed for ATCC 19606. (B) Western blot analysis of lysates from A. baumannii strains to assess: (i) legionaminic acid reactivity using LUH5533 (K7), SDF (K5), LUH5551 (K63), NIPH-329 (K46), A74 (K2), and ATCC 19606 (K3); (ii) acinetaminic acid reactivity using D36 (K12), UMB001 (K13), SGH0703 (K73), A74 (K2), and ATCC 19606 (K3) and (iii) additional pseudaminic acid reactivity using AUSMDU00058681 (K90) and MRSN31468 (K58). The A74 (K2 CPS with Pse) and ATCC 19606 (K3 CPS lacking Pse) serve as positive and negative controls, respectively. (C) SNFG diagrams of the various A. baumannii CPS K-type monomers used to generate this figure.
Extended Data Fig. 9 Immunofluorescence imaging-based opsonization assays of A. baumannii A74.
(A) Density plots of biological replicates assessing the intracellular number of A. baumannii A74 in THP-1 macrophages treated in the absence of added antibody, or in the presence of Pse 1E8 or a mouse IgG1 isotype control with >200 cell assessed for each biological replicate. (B) Violin plots depicting the abundance of intracellular bacteria in THP-1 macrophages treated with A. baumannii A74 in the absence of added antibody, or in the presence of Pse 1E8 or a mouse IgG1 isotype control. Statistical analysis corresponding to pairwise two-sided student t-tests with p-values less then 0.001 denoted by *** and corresponding to p-values = 2.88×10−36 and 9.32×10−29. Statistical analysis was undertaken on the combined data from four biological replicates corresponding to n > 900 cells per group. The boxplot denotes the upper (Q3) and lower (Q1) quartiles of the observed data ranges, with the median denoted between these ranges. The whiskers denote 1.5 times the interquartile Range of Q1 and Q3, excluding outliers. (C) A representative immunofluorescence microscopy micrograph of THP-1 cells one hour after infection with A. baumannii A74. DNA has been stained with Hoechst 33342 (blue), actin with SiR-Actin (red), and Pse mAb 1E8 (green). Scale bar is 5 μm.
Extended Data Fig. 10 Surface-specific binding and opsonophagocytosis of H. pylori.
(A) In vitro gentamicin protection assays of H. pylori strains in response to pretreatment with 1E8 Pse-specific antibody, isotype control, or PBS (n = 3 independent experiments for each condition). Box and whisker plots indicate minimum, first quartile, median, third quartile, and maximum values. Kruskal–Wallis tests gave p-values < 0.05 (*) and <0.01 (**). (B) Flow cytometry analysis of H. pylori strains either unstained or stained with α-Pse mAb alone, α-mouse-AlexaFluor647 alone, or both α-Pse mAb 1E8 and α-mouse-AlexaFluor647.
Supplementary information
Supplementary Information
Supplementary Figs. 1–86, Tables 1–3, Data 1–6 captions and Note.
Supplementary Data 1
Glycoproteomic data for H. pylori P12 flagellin preparation.
Supplementary Data 2
Enriched H. pylori P12 glycopeptides.
Supplementary Data 3
Glycoproteomic data for H. pylori 26695.
Supplementary Data 4
Enriched C. jejuni glycopeptides.
Supplementary Data 5
Glycoproteomic data for A. baumannii A74.
Supplementary Data 6
Glycoproteomic data for A. baumannii BAL062.
Source data
Source Data Figs. 2 and 4–6 and Extended Data Figs. 5 and 8–10
Unprocessed western blots and gels, volcano plot source data, open search plot source data, SPR source data, BLI source data, ELISA plot source data, box-and-whisker plot source data, Kaplan–Meier curve and CFU source data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tang, A.H., Soler, N.M., Karlic, K.I. et al. Uncovering bacterial pseudaminylation with pan-specific antibody tools. Nat Chem Biol (2026). https://doi.org/10.1038/s41589-025-02114-9
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41589-025-02114-9